Article
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.
Thrombosis and haemostasis - 1 Feb 2018
Stanne Tara M, Olsson Maja, Lorentzen Erik, Pedersen Annie, Gummesson Anders, Gils Ann, Jood Katarina, Engström Gunnar, Melander Olle, Declerck Paul J, Jern Christina
Abstract excerpt
Thrombin-activatable fibrinolysis inhibitor (TAFI) plays a central role in haemostasis, and plasma TAFI concentrations are heritable. Candidate gene studies have identified several variants within the gene encoding TAFI, CPB2, that explain part of the estimated heritability. Here, we describe an exploratory genome-wide association study to identify novel variants within and outside of the CPB2 locus that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
